Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: Application to cardiac transplant recipients

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1538-1541

  Lemaitre, Florian ^a,b,c,d   Antignac, Marie ^d,e   Fernandez, Christine ^d,e  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d EA4123   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

Cardiac transplant recipients; Heart transplantation; PBMC; Peripheral blood mononuclear cells; Pharmacokinetics; Tacrolimus; Transplantation

Indexed keywords

ADVAGRAFT; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY;

CARDIAC TRANSPLANT RECIPIENTS; HEART TRANSPLANTATION; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHARMACOKINETICS; TACROLIMUS; TRANSPLANTATION;

ADULT; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; DRUG MONITORING; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84884352957     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.02.011     Document Type: Article

References (12)

1. Staatz C.E., Tett S.E. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004, 43:623-653.
2. Oellerich M., Armstrong V.W., Schütz E., Shaw L.M. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem 1998, 31:309-316.
3. Ekberg H., Tedesco-Silva H., Demirbas A., Vítko S., Nashan B., Gürkan A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007, 357:2562-2575.
4. Wallemacq P., Armstrong V.W., Brunet M., Haufroid V., Holt D.W., Johnston A., et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European Consensus Conference. Ther Drug Monit 2009, 31:139-152.
5. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004, 351:2715-2729.
6. Falck P., Asberg A., Guldseth H., Bremer S., Akhlaghi F., Reubsaet J.L., et al. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation 2008, 85:179-184.
7. Capron A., Mourad M., De Meyer M., De Pauw L., Eddour D.C., Latinne D., et al. CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. Pharmacogenomics 2010, 11:703-714.
8. Capron A., Lerut J., Verbaandert C., Mathys J., Ciccarelli O., Vanbinst R., et al. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther Drug Monit 2009, 31:178-186.
9. Capron A., Lerut J., Latinne D., Rahier J., Haufroid V., Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int 2012, 25:41-47.
10. Roullet-Renoleau F., Lemaitre F., Antignac M., Zahr N., Farinotti R., Fernandez C. Everolimus quantification in peripheral blood mononuclear cells using ultra high performance liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2012, 66:278-281.
11. International Conference of Harmonization. Q2A Text on validation of analytical procedures March 1995.
12. International Conference of Harmonization. Q2B Validation of analytical procedures: Methodology May 1997.